In our study, we demonstrated that HIGD2A knockdown decreased mitochondrial ATP production, mediated mitochondrial stress, led to cell cycle arrest in the S phase, and inhibited the proliferation of HCC cells. Here, HIGD2A is linked to hepatocellular carcinoma.